Abrupt FDA ex­its spark con­cern; Un­pack­ing key con­cepts at gene ther­a­py sum­mit; 20 lu­mi­nar­ies who re­shaped R&D; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

As Twit­ter folks would say, what a month this past week has been! I’d rec­om­mend go­ing through this re­port care­ful­ly to find the big news that prob­a­bly got buried un­der even big­ger news. For those of you who sub­scribe to our dai­ly newslet­ters, we will be off on Mon­day in ob­ser­vance of La­bor Day in the US and will be back on Mon­day. I’m ready to take in the long week­end — and hope yours is just what you need it to be.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.